The International Diabetes Closed Loop (iDCL) Trial: Protocol 1

NACompletedINTERVENTIONAL
Enrollment

127

Participants

Timeline

Start Date

October 27, 2017

Primary Completion Date

September 4, 2018

Study Completion Date

September 4, 2018

Conditions
Type1 Diabetes Mellitus
Interventions
DEVICE

Artificial Pancreas

Use of CTR at home for 3 months

OTHER

Sensor Augmented Therapy

Use of personal pump with study CGM \& glucometer at home for 3 months

Trial Locations (7)

10029

Icahn School of Medicine at Mount Sinai, New York

22903

University of Virginia Center for Diabetes Technology, Charlottesville

55905

Mayo Clinic, Rochester

80045

Barbara Davis Center, University of Colorado, Aurora

93105

William Sansum Diabetes Center, Santa Barbara

94304

Stanford University, Stanford

02215

Harvard University (Joslin Diabetes Center), Boston

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Jaeb Center for Health Research

OTHER

collaborator

TypeZero Technologies

INDUSTRY

collaborator

DexCom, Inc.

INDUSTRY

collaborator

Roche Diagnostic Ltd.

INDUSTRY

collaborator

Ascensia Diabetes Care

INDUSTRY

lead

University of Virginia

OTHER